How much is the Endometriosis Treatment Market?

USD 8,427.32 Million (2035) is the Endometriosis Treatment Market Read More

What is the growth rate of the Endometriosis Treatment Market?

13.5% is the growth rate of the Endometriosis Treatment Market Read More

Which region held the largest market share in the Endometriosis Treatment Market?

North America held the largest market share in the Endometriosis Treatment Market. Read More

Who are the key players in the Endometriosis Treatment Market?

Pfizer Inc., Medtronic, AstraZeneca, F. Hoffmann-la Roche Ltd, Haleon Plc, AbbVie Inc., Bayer AG, Sanofi, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd. Read More

Which Application had the largest market share in the Endometriosis Treatment Market?

Hospitals & Clinics had the largest market share in the Endometriosis Treatment Market. Read More

Endometriosis treatment Market

ID: MRFR/HC/19126-CR

128 Pages

Vikita Thakur

Last Updated: April 29, 2026

Endometriosis Treatment Market Research Report: Information by Treatment Type (Medication, Acupuncture Therapy, and Surgery), By End User (Hospitals & Clinics, Homecare Settings, and others), By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) -Global Forecast to 2035.

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 EXECUTIVE SUMMARY
1. 1.1 MARKET ATTRACTIVENESS ANALYSIS
2. 1.2 GLOBAL ENDOMETRIOSIS TREATMENTMARKET, BY TREATMENT TYPE
3. 1.3 GLOBAL ENDOMETRIOSIS TREATMENTMARKET, BY END USE
2 MARKET INTRODUCTION
1. 2.1 DEFINITION
2. 2.2 SCOPE OF THE STUDY
3. 2.3 RESEARCH OBJECTIVE
4. 2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
1. 3.1 OVERVIEW
2. 3.2 DATA FLOW
  1. 3.2.1 Data Mining Process
3. 3.3 PURCHASED DATABASE:
4. 3.4 SECONDARY SOURCES:
  1. 3.4.1 Secondary Research data flow:
5. 3.5 PRIMARY RESEARCH:
  1. 3.5.1 Primary Research Data Flow:
  2. 3.5.2 Primary Research: Number of Interviews conducted
  3. 3.5.3 Primary Research: Regional Coverage
6. 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  1. 3.6.1 Revenue Analysis Approach
7. 3.7 DATA FORECASTING
  1. 3.7.1 Data forecasting Type
8. 3.8 DATA MODELING
  1. 3.8.1 microeconomic factor analysis:
  2. 3.8.2 Data modeling:
9. 3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
1. 4.1 INTRODUCTION
2. 4.2 DRIVERS
  1. 4.2.1 Increasing Adoption of Hormonal Therapies for Symptom Management
  2. 4.2.2 INCREASING PREVALENCE OF ENDOMETRIOSIS
  3. 4.2.3 Growing Use of Combination and Long-Term Drug Therapies
  4. 4.2.4 Increasing Treatment Uptake for Endometriosis-Associated Pain and Infertility
3. 4.3 RESTRAINTS
  1. 4.3.1 High Treatment Costs and Limited Reimbursement in Some Regions
  2. 4.3.2 SIDE EFFECTS ASSOCIATED WITH HORMONAL THERAPIES
  3. 4.3.3 Lack of Curative Treatments and High Disease Recurrence
4. 4.4 OPPORTUNITIES
  1. 4.4.1 INCREASING INVESTMENT IN WOMEN’S HEALTH
  2. 4.4.2 Expansion of Pipeline Drugs and Clinical Research
5 MARKET FACTOR ANALYSIS
1. 5.1 REGULATORY ENVIRONMENT & COMPLIANCE
2. 5.2 TECHNOLOGICAL TRENDS & INNOVATION
3. 5.3 PATIENT DEMOGRAPHICS & DISEASE BURDENS
4. 5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS
  1. 5.4.1 North America
  2. 5.4.2 europe
  3. 5.4.3 asia pacific
  4. 5.4.4 rest of the world
  5. 5.4.5 reimbursement dynamics
5. 5.5 MARKET ENTRY & EXIT BARRIERS
  1. 5.5.1 Barriers to Entry
  2. 5.5.2 Barriers to exit
6. 5.6 PARTNERSHIPS & COLLABORATIONS
7. 5.7 CONSUMER & HEALTHCARE PROVIDER PREFERENCES
  1. 5.7.1 Consumer Preferences
  2. 5.7.2 HEALTHCARE PROVIDER Preferences
8. 5.8 PESTLE ANALYSIS
  1. 5.8.1 POLITICAL FACTORS
  2. 5.8.2 Economic FACTORS
  3. 5.8.3 SOCIAL FACTORS
  4. 5.8.4 TECHNOLOGICAL FACTORS
  5. 5.8.5 LEGAL FACTORS
  6. 5.8.6 ENVIRONMENTAL FACTORS
9. 5.9 PORTER'S FIVE FORCES MODEL
  1. 5.9.1 Threat of New Entrants
  2. 5.9.2 BARGAINING POWER OF SUPPLIERS
  3. 5.9.3 Threat of Substitutes
  4. 5.9.4 Bargaining Power of Buyers
  5. 5.9.5 Intensity of Rivalry
10. 5.10 PRODUCT PIPELINE ANALYSIS
11. 5.11 CASE STUDY ANALYSIS
12. 5.12 INVESTMENT & FUNDING SCENARIOS
13. 5.13 POST-MARKET SURVEILLANCE & SAFETY DATA
14. 5.14 DISEASE OVERVIEW
15. 5.15 DIAGNOSIS
16. 5.16 CURRENT TREATMENT
6 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE
1. 6.1 OVERVIEW
7 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY END USER
1. 7.1 OVERVIEW
8 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY REGION
1. 8.1 OVERVIEW
2. 8.2 NORTH AMERICA
  1. 8.2.1 us
  2. 8.2.2 canada
3. 8.3 EUROPE
  1. 8.3.1 germany
  2. 8.3.2 UK
  3. 8.3.3 france
  4. 8.3.4 netherlands
  5. 8.3.5 italy
  6. 8.3.6 spain
  7. 8.3.7 Rest of Europe
4. 8.4 ASIA PACIFIC
  1. 8.4.1 China
  2. 8.4.2 india
  3. 8.4.3 japan
  4. 8.4.4 South korea
  5. 8.4.5 malaysia
  6. 8.4.6 thailand
  7. 8.4.7 Indonesia
  8. 8.4.8 rest of asia pacific
5. 8.5 LATAM
  1. 8.5.1 brazil
  2. 8.5.2 mexico
  3. 8.5.3 argentina
  4. 8.5.4 rest of Latin America
6. 8.6 MIDDLE EAST AND AFRICA
  1. 8.6.1 GCC COUNTRIES
  2. 8.6.2 SOUTH AFRICA
  3. 8.6.3 Rest of Middle East and Africa
9 COMPETITIVE LANDSCAPE
1. 9.1 INTRODUCTION
2. 9.2 MARKET SHARE ANALYSIS, 2025
3. 9.3 COMPETITOR DASHBOARD
4. 9.4 PUBLIC PLAYERS STOCK SUMMARY
5. 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
6. 9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
  1. 9.1.1 Product Approval
10 COMPANY PROFILES
1. 10.1 PFIZER INC.
  1. 10.1.1 COMPANY OVERVIEW
  2. 10.1.2 FINANCIAL OVERVIEW
  3. 10.1.3 PRODUCTS OFFERED
  4. 10.1.4 KEY DEVELOPMENTS
  5. 10.1.5 SWOT ANALYSIS
  6. 10.1.6 KEY STRATEGIES
2. 10.2 MEDTRONIC
  1. 10.2.1 COMPANY OVERVIEW
  2. 10.2.2 FINANCIAL OVERVIEW
  3. 10.2.3 Products OFFERED
  4. 10.2.4 KEY DEVELOPMENTs
  5. 10.2.5 SWOT ANALYSIS
  6. 10.2.6 KEY STRATEGIES
3. 10.3 ASTRAZENECA
  1. 10.3.1 COMPANY OVERVIEW
  2. 10.3.2 FINANCIAL OVERVIEW
  3. 10.3.4 KEY DEVELOPMENTS
  4. 10.3.5 KEY STRATEGIES
4. 10.4 F. HOFFMANN-LA ROCHE LTD.
  1. 10.4.1 COMPANY OVERVIEw
  2. 10.4.2 FINANCIAL OVERVIEW
  3. 10.4.4 KEY DEVELOPMENTs
  4. 10.4.5 KEY STRATEGIES
5. 10.5 HALEON PLC
  1. 10.5.1 COMPANY OVERVIEW
  2. 10.5.2 FINANCIAL OVERVIEW
  3. 10.5.4 KEY DEVELOPMENTs
  4. 10.5.5 KEY STRATEGIES
6. 10.6 ABBVIE INC.
  1. 10.6.1 COMPANY OVERVIEw
  2. 10.6.2 FINANCIAL OVERVIEW
  3. 10.6.3 products OFFERed
  4. 10.6.4 KEY DEVELOPMENTs
  5. 10.6.5 SWOT ANALYSIS
  6. 10.6.6 KEY STRATEGIES
7. 10.7 BAYER AG
  1. 10.7.1 COMPANY OVERVIEW
  2. 10.7.2 FINANCIAL OVERVIEW
  3. 10.7.3 productS OFFERED
  4. 10.7.4 KEY DEVELOPMENTs
  5. 10.7.5 SWOT ANALYSIS
  6. 10.7.6 KEY STRATEGIES
8. 10.8 SANOFI
  1. 10.8.1 COMPANY OVERVIEW
  2. 10.8.2 FINANCIAL OVERVIEW
  3. 10.8.3 products OFFERed
  4. 10.8.4 KEY DEVELOPMENTs
  5. 10.8.5 SWOT ANALYSIS
  6. 10.8.6 Key Strategy
9. 10.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
  1. 10.9.1 COMPANY OVERVIEW
  2. 10.9.2 FINANCIAL OVERVIEW
  3. 10.9.3 Products OFFERed
  4. 10.9.4 KEY DEVELOPMENTS
  5. 10.9.5 KEY STRATEGIES
10. 10.10 SUN PHARMACEUTICAL INDUSTRIES LTD.
  1. 10.10.1 COMPANY OVERVIEW
  2. 10.10.2 FINANCIAL OVERVIEW
  3. 10.10.3 productS OFFERED
  4. 10.10.4 KEY DEVELOPMENTs
  5. 10.10.5 KEY STRATEGIES
11. 10.11 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 NORTH AMERICA PRICING ANALYSIS, BY PRODUCT
TABLE 3 EUROPE PRICING ANALYSIS, BY PRODUCT
TABLE 4 ASIA PACIFIC PRICING ANALYSIS, BY PRODUCT
TABLE 5 REST OF THE WORLD PRICING ANALYSIS, BY PRODUCT
TABLE 6 PRODUCT PIPELINE
TABLE 7 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 8 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2035 (USD MILLION)
TABLE 9 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, END USER, 2019-2035 (USD MILLION)
TABLE 10 GLOBAL ENDOMETRIOSIS MARKET, BY REGION, 2019-2035 (USD MILLION)
TABLE 11 NORTH AMERICA ENDOMETRIOSIS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 12 NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 13 NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2035 (USD MILLION)
TABLE 14 NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET, END USER, 2019-2035 (USD MILLION)
TABLE 15 US ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 16 US ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2035 (USD MILLION)
TABLE 17 US ENDOMETRIOSIS TREATMENT MARKET, END USER, 2019-2035 (USD MILLION)
TABLE 18 CANADA ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 19 CANADA ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2035 (USD MILLION)
TABLE 20 CANADA ENDOMETRIOSIS TREATMENT MARKET, END USER, 2019-2035 (USD MILLION)
TABLE 21 EUROPE ENDOMETRIOSIS TREATMENT MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 22 EUROPE ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 23 EUROPE ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 24 EUROPE ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 25 GERMANY ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 26 GERMANY ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 27 GERMANY ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 28 UK ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 29 UK ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 30 UK ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 31 FRANCE ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 32 FRANCE ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 33 FRANCE ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 34 NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 35 NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 36 NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 37 ITALY ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 38 ITALY ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 39 ITALY ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 40 SPAIN ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 41 SPAIN ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 42 SPAIN ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 43 REST OF EUROPE ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 44 REST OF EUROPE ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 45 REST OF EUROPE ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 46 ASIA PACIFIC ENDOMETRIOSIS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 47 ASIA PACIFIC ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 48 ASIA PACIFIC ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 49 ASIA PACIFIC ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 50 CHINA ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 51 CHINA ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 52 CHINA ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 53 INDIA ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 54 INDIA ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 55 INDIA ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 56 JAPAN ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 57 JAPAN ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 58 JAPAN ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 59 SOUTH KOREA ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 60 SOUTH KOREA ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 61 SOUTH KOREA ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 62 MALAYSIA ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 63 MALAYSIA ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 64 MALAYSIA ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 65 THAILAND ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 66 THAILAND ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 67 THAILAND ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 68 INDONESIA ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 69 INDONESIA ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 70 INDONESIA ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 71 REST OF ASIA PACIFIC ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 72 REST OF ASIA PACIFIC ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 73 REST OF ASIA PACIFIC ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 74 LATAM ENDOMETRIOSIS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 75 LATAM ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 76 LATAM ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 77 LATAM ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 78 BRAZIL ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 79 BRAZIL ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 80 BRAZIL ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 81 MEXICO ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 82 MEXICO ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 83 MEXICO ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 84 ARGENTINA ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 85 ARGENTINA ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 86 ARGENTINA ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 87 REST OF LATIN AMERICA ENDOMETRIOSIS MARKET, BY TREATMENT, 2019-2035 (USD MILLION)
TABLE 88 REST OF LATIN AMERICA ENDOMETRIOSIS MARKET, BY MEDICATION, 2019-2035 (USD MILLION)
TABLE 89 REST OF LATIN AMERICA ENDOMETRIOSIS MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 90 MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 91 MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 92 MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 93 MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 94 GCC COUNTRIES ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 95 GCC COUNTRIES ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 96 GCC COUNTRIES ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 97 SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 98 SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 99 SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 100 REST OF MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2019-2035 (USD MILLION)
TABLE 101 REST OF MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, FOR MEDICATION, 2019-2035 (USD MILLION)
TABLE 102 REST OF MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY END USE, 2019-2035 (USD MILLION)
TABLE 103 PRODUCT APPROVAL
TABLE 104 PFIZER INC.: PRODUCTS OFFERED
TABLE 105 PFIZER INC.: KEY DEVELOPMENTS
TABLE 106 MEDTRONIC: SERVICES OFFERED
TABLE 110 ABBVIE, INC.: PRODUCTS OFFERED
TABLE 111 BAYER AG: PRODUCT OFFERED
TABLE 112 SANOFI.: PRODUCTS OFFERED
TABLE 113 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS OFFERED
TABLE 114 SUN PHARMACEUTICAL INDUSTRIES LTD. : PRODUCT OFFERED
LIST OF FIGURES
FIGURE 1 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ENDOMETRIOSIS TREATMENTMARKET, 2025
FIGURE 2 GLOBAL ENDOMETRIOSIS TREATMENTMARKET ANALYSIS, BY TREATMENT TYPE, 2025 (USD MILLION AND %)
FIGURE 3 GLOBAL ENDOMETRIOSIS TREATMENTMARKET ANALYSIS, BY END USE, 2025 (USD MILLION AND %)
FIGURE 1 GLOBAL ENDOMETRIOSIS MARKET: STRUCTURE
FIGURE 2 GLOBAL ENDOMETRIOSIS MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035)
FIGURE 3 GLOBAL ENDOMETRIOSIS MARKET DRIVER: IMPACT ANALYSIS
FIGURE 4 GLOBAL ENDOMETRIOSIS MARKET RESTRAINT: IMPACT ANALYSIS
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ENDOMETRIOSIS TREATMENT MARKET
FIGURE 6 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, TREATMENT TYPE SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION)
FIGURE 7 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY TREATMENT TYPE, 2025 & 2035 (USD MILLION)
FIGURE 8 GLOBAL ENDOMETRIOSIS TREATMENT MARKET SHARE (%), BY TREATMENT TYPE, 2025
FIGURE 9 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, END USER SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION)
FIGURE 10 GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY END USER, 2025 & 2035 (USD MILLION)
FIGURE 11 GLOBAL ENDOMETRIOSIS TREATMENT MARKET SHARE (%), BY END USER, 2025
FIGURE 12 GLOBAL ENDOMETRIOSIS MARKET, BY REGION, 2025 & 2035 (USD MILLION)
FIGURE 13 GLOBAL ENDOMETRIOSIS MARKET SHARE (%), BY REGION, 2025
FIGURE 14 NORTH AMERICA ANALYSIS: ENDOMETRIOSIS MARKET, 2019-2035 (USD MILLION)
FIGURE 15 NORTH AMERICA MARKET ANALYSIS: ENDOMETRIOSIS TREATMENT MARKET, 2019-2035 (USD MILLION)
FIGURE 16 NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
FIGURE 17 EUROPE ANALYSIS: ENDOMETRIOSIS MARKET, 2019-2035 (USD MILLION)
FIGURE 18 EUROPE MARKET ANALYSIS: ENDOMETRIOSIS TREATMENT MARKET, 2019-2035 (USD MILLION)
FIGURE 19 EUROPE ENDOMETRIOSIS TREATMENT MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
FIGURE 20 ASIA PACIFIC: SWOT ANALYSIS
FIGURE 21 ASIA PACIFIC ENDOMETRIOSIS MARKET, BY REGION, 2025 & 2035 (USD MILLION)
FIGURE 22 ASIA PACIFIC ENDOMETRIOSIS MARKET SHARE (%), BY COUNTRY, 2025
FIGURE 23 LATAM: SWOT ANALYSIS
FIGURE 24 LATAM ENDOMETRIOSIS MARKET, BY REGION, 2025 & 2035 (USD MILLION)
FIGURE 25 LATAM ENDOMETRIOSIS MARKET SHARE (%), BY COUNTRY, 2025
FIGURE 26 MIDDLE EAST AND AFRICA MARKET ANALYSIS: ENDOMETRIOSIS TREATMENT MARKET, 2019-2035 (USD MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA ENDOMETRIOSIS TREATMENT MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
FIGURE 28 GLOBAL ENDOMETRIOSIS TREATMENT MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025
FIGURE 29 COMPETITOR DASHBOARD: GLOBAL ENDOMETRIOSIS TREATMENT MARKET
FIGURE 30 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 PFIZER INC.: SWOT ANALYSIS
FIGURE 32 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 MEDTRONIC: SWOT ANALYSIS
FIGURE 34 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 HALEON PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 ABBVIE, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 ABBVIE, INC.: SWOT ANALYSIS
FIGURE 39 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 BAYER AG : SWOT ANALYSIS
FIGURE 41 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 SANOFI: SWOT ANALYSIS
FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 SUN PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT

Certified Researchers

Customize Report

Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)

Medication
Acupuncture Therapy
Surgery

Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)

Hospitals & Clinics
Homecare Settings
Others

Endometriosis Treatment Market Regional Outlook (USD Million, 2019-2035)

North America Outlook (USD Million, 2019-2035)
North America Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
North America Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- US Outlook (USD Million, 2019-2035)
US Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
US Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Canada Outlook (USD Million, 2019-2035)
Canada Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Canada Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
Europe Outlook (USD Million, 2019-2035)
Europe Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Europe Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- GermanyOutlook (USD Million, 2019-2035)
Germany Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Germany Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- UK Outlook (USD Million, 2019-2035)
UK Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
UK Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others

France Outlook (USD Million, 2019-2035)

France Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
France Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Russia Outlook (USD Million, 2019-2035)
Russia Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Russia Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Italy Outlook (USD Million, 2019-2035)
Italy Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Italy Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Spain Outlook (USD Million, 2019-2035)
Spain Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Spain Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Rest Of Europe Outlook (USD Million, 2019-2035)
Rest Of Europe Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Rest Of Europe Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
Asia-Pacific Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- China Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- India Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Japan Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- South Korea Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Rest of Asia-Pacific Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
South America Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Brazil Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Mexico Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Argentina Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Rest of South America Outlook (USD Million, 2019-2035)
Rest of South America Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Rest of South America Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
Middle East & Africa Outlook (USD Million, 2019-2035)
Middle East & Africa Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Middle East & Africa Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- GCC Countries Outlook (USD Million, 2019-2035)
Global Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Global Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- South Africa Outlook (USD Million, 2019-2035)
South Africa Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
South Africa Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others
- Rest of Middle East & Africa Outlook (USD Million, 2019-2035)
Rest of Middle East & Africa Endometriosis Treatment Market by Treatment Type Outlook (USD Million, 2019-2035)
Medication
Acupuncture Therapy
Surgery
Rest of Middle East & Africa Endometriosis Treatment Market by End User Outlook (USD Million, 2019-2035)
Hospitals & Clinics
Homecare Settings
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”